Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
Promising Interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement
Promising Interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement